Apollo Medical (NASDAQ: AMEH) is one of 29 publicly-traded companies in the “Management consulting services” industry, but how does it weigh in compared to its peers? We will compare Apollo Medical to related companies based on the strength of its valuation, earnings, analyst recommendations, institutional ownership, risk, dividends and profitability.
Volatility & Risk
Apollo Medical has a beta of -1.17, suggesting that its stock price is 217% less volatile than the S&P 500. Comparatively, Apollo Medical’s peers have a beta of 1.08, suggesting that their average stock price is 8% more volatile than the S&P 500.
This table compares Apollo Medical and its peers gross revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Apollo Medical||$519.91 million||$10.84 million||64.97|
|Apollo Medical Competitors||$1.71 billion||$120.52 million||26.83|
Apollo Medical’s peers have higher revenue and earnings than Apollo Medical. Apollo Medical is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
This table compares Apollo Medical and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Apollo Medical Competitors||-20.27%||-9.55%||-10.93%|
Insider & Institutional Ownership
6.7% of Apollo Medical shares are owned by institutional investors. Comparatively, 62.2% of shares of all “Management consulting services” companies are owned by institutional investors. 20.5% of Apollo Medical shares are owned by insiders. Comparatively, 13.7% of shares of all “Management consulting services” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
This is a summary of recent recommendations for Apollo Medical and its peers, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Apollo Medical Competitors||159||488||664||40||2.43|
Apollo Medical presently has a consensus price target of $25.00, indicating a potential upside of 32.70%. As a group, “Management consulting services” companies have a potential upside of 15.33%. Given Apollo Medical’s stronger consensus rating and higher probable upside, equities analysts plainly believe Apollo Medical is more favorable than its peers.
Apollo Medical beats its peers on 8 of the 13 factors compared.
About Apollo Medical
Apollo Medical Holdings, Inc., an integrated health care delivery and management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. The company serves the patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organizations; and non-insured patients in California. Apollo Medical Holdings, Inc. is based in Alhambra, California.
Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.